EUVIMEDEUVIMED entdecken
Open Access

Comprehensive Genomic Profiling of Sinonasal Carcinomas: Identification of Common Mutations and Potential Targets for Therapy

Gabriel Bitar, Beau Hsia iD, Saif Alshaka, Bastien A Valencia, Jeeho Kim, Mariko Sato, John Crawford, Michael L Levy, Sean Polster, Vijay A Patel

Journal of Neurological Surgery Part B: Skull Base · 01.06.2026 · 87 (03) · 337-344

DOI: 10.1055/a-2639-5790 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.06.2026. Verfasst von Gabriel Bitar und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Creighton University, Phoenix, Arizona, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sinonasal cancers are malignant neoplasms arising from the nasal cavity and paranasal sinuses, including squamous cell carcinoma (SCC), adenocarcinoma, and undifferentiated carcinoma. Due to their rarity, comprehensive genomic data remain limited. Treatments include surgery, radiation, and chemotherapy, with ongoing trials investigating agents like cetuximab, cisplatin, and Tazemetostat. We analyzed sinonasal cancer cases from the American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) database via cBioPortal (v16.1-public, accessed July 22, 2024). Common gene mutations, correlations, and mutual exclusivities were assessed using statistical analyses with false discovery rate correction. Of 2,595 head and neck cancer samples, 122 (4.7%) were sinonasal carcinoma: 70 (57.4%) SCC, 31 (25.4%) undifferentiated carcinoma, and 21 (17.2%) adenocarcinomas. The most frequent mutations were TP53 (tumor protein 53; 40%), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; 14%), KMT2D (lysine methyltransferase 2D; 11%), and CDKN2A (cyclin-dependent kinase inhibitor 2A; 9%). Subtype-specific mutations included IDH2 (isocitrate dehydrogenase; 230%) in undifferentiated carcinoma and FAT1 (15%) in adenocarcinoma. TP53 frequently co-occurred with PRKDC (protein kinase, DNA-activated, catalytic subunit; p = 0.020), while KMT2D co-occurred with PIK3CA (p = 0.018). TP53, PIK3CA, and KMT2D mutations are prevalent in sinonasal carcinoma, highlighting potential targets for therapy. Tazemetostat, targeting KMT2D-related DNA (deoxyribonucleic acid) methylation, and cetuximab, targeting the PIK3CA signaling cascade, may offer therapeutic benefits. Further research on mutation-specific therapies could improve treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

PI3K/AKT pathwayPIK3CA mutationTP53 mutationepigenetic modulationgenomic profilingprecision oncologysinonasal carcinomatargeted therapies

Autor:innen und Institutionen

  • School of Medicine, Creighton University, Phoenix, Arizona, United States.
  • Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic Florida, Jacksonville, Florida, United States.
  • Department of Otolaryngology-Head and Neck Surgery, Naval Medical Center San Diego, San Diego, California, United States.
  • Department of Pediatric Oncology, Children's Hospital of Orange County, Orange, California, United States.
  • Children's Hospital Orange County, University of California Irvine, Department of Pediatrics and Neurology, Orange, California, United States.
  • Department of Neurosurgery, University of California San Diego-Rady Children's Hospital, San Diego, California, United States.

ORCID-Profile: Beau Hsia

Zitieren

APA

Bitar, G., Hsia, B., Alshaka, S., Valencia, B. A., Kim, J., Sato, M., Crawford, J., Levy, M. L., Polster, S., & Patel, V. A. (2026). Comprehensive Genomic Profiling of Sinonasal Carcinomas: Identification of Common Mutations and Potential Targets for Therapy. Journal of Neurological Surgery Part B: Skull Base, 87(03), 337-344. https://doi.org/10.1055/a-2639-5790

Vancouver

Bitar G, Hsia B, Alshaka S, Valencia BA, Kim J, Sato M, et al. Comprehensive Genomic Profiling of Sinonasal Carcinomas: Identification of Common Mutations and Potential Targets for Therapy. Journal of Neurological Surgery Part B: Skull Base. 2026;87(03):337-344. doi:10.1055/a-2639-5790

BibTeX
@article{Bitar2026,
  author = {Bitar, Gabriel and Hsia, Beau and Alshaka, Saif and Valencia, Bastien A and Kim, Jeeho and Sato, Mariko and Crawford, John and Levy, Michael L and Polster, Sean and Patel, Vijay A},
  title = {Comprehensive Genomic Profiling of Sinonasal Carcinomas: Identification of Common Mutations and Potential Targets for Therapy},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2026},
  volume = {87},
  number = {03},
  pages = {337--344},
  doi = {10.1055/a-2639-5790}
}
Kostenlos starten →